Severe hyperglycemia induced by olanzapine was improved with a recovery of insulin secretion after switching to risperidone and introducing insulin therapy

Internal Medicine

Volumn 49, Issue 23, 2010, Pages 2635-2637

  Nakamura, Masaru ^a   Nagamine, Takahiko ^b  

^a Kosekai Kusatsu Hospital   (Japan)

^b Seiwakai Kitsunan Hospital   (Japan)

Author keywords

HOMA IR; Insulin secretion; Olanzapine; Schizophrenia

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; OLANZAPINE; ORAL ANTIDIABETIC AGENT; RISPERIDONE; SHORT ACTING DRUG;

ADULT; ARTICLE; CASE REPORT; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN TREATMENT; SCHIZOPHRENIA; THIRST; WEIGHT REDUCTION;

ADULT; BENZODIAZEPINES; DRUG SUBSTITUTION; FEMALE; HUMANS; HYPERGLYCEMIA; INSULIN; RECOVERY OF FUNCTION; RISPERIDONE; SEVERITY OF ILLNESS INDEX;

EID: 78649803743     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.4397     Document Type: Article

References (9)

1. Newcomer JW, Haupt DW, Fucetola R, et al. Abnormalities in glucose regulation during antipsychotic treatment of shizophrenia. Arch Gen Psychiatry 59: 337-345, 2002.
2. Henderson DC, Cagliero E, Copeland PM, et al. Glucose metabolism in patients with schizophrenia treated with antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psychiatry 62: 19-28,
3. Nagamine T. Hypoglycemia associated with insulin hypersecretion following the addition of olanzapine to conventional antipsychotics. Neuropsychiatr Dis and Treat 2: 583-585, 2006.
4. Melkersson K. Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro. Eur Neuropsychopharmacol 14: 115-119, 2004.
5. Gautam D, Han SJ, Hamdan FF, et al. A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vitro. Cell Metab 3: 449-461,
6. Johnson DE, Yamazaki H, Ward KM, et al. Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychoticinduced diabetes and hyperglycemia. Diabetes 54: 1552-1558,
7. Silvestre JS, Prous J. Research on adverse drug events. 1. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes. Methods Find Exp Clin Pharmacol 27: 289-304, 2005.
8. Nasrallah HA. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry 13: 27-35, 2008.
9. Starrenburg FC, Bogers JP. How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins. Eur Psychiatry 24: 164-170, 2009.